These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 35595834)

  • 1. Breakthroughs in hepatitis C research: from discovery to cure.
    Manns MP; Maasoumy B
    Nat Rev Gastroenterol Hepatol; 2022 Aug; 19(8):533-550. PubMed ID: 35595834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic hepatitis C: from discovery to cure].
    Li Q; Huang YX; Chen L
    Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):708-712. PubMed ID: 27788732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. THE GORDON WILSON LECTURE: THE HEPATITIS C VIRUS: FROM HIPPOCRATES TO CURE.
    Alter HJ
    Trans Am Clin Climatol Assoc; 2019; 130():104-118. PubMed ID: 31516174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and Development of Antiviral Therapies for Chronic Hepatitis C Virus Infection.
    Martinez MA; Franco S
    Adv Exp Med Biol; 2021; 1322():139-157. PubMed ID: 34258740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C.
    Martinello M; Solomon SS; Terrault NA; Dore GJ
    Lancet; 2023 Sep; 402(10407):1085-1096. PubMed ID: 37741678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal screening for hepatitis C - in for a penny, in for a pound.
    Garrido I; Macedo G
    Eur J Clin Microbiol Infect Dis; 2022 Mar; 41(3):341-347. PubMed ID: 35022892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of acute and chronic hepatitis C.
    Maasoumy B; Wedemeyer H
    Best Pract Res Clin Gastroenterol; 2012 Aug; 26(4):401-12. PubMed ID: 23199500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should we continue surveillance for hepatocellular carcinoma and gastroesophageal varices in patients with cirrhosis and cured HCV infection?
    Isfordink CJ; Maan R; de Man RA; van Erpecum KJ; van der Meer AJ
    Eur J Intern Med; 2021 Dec; 94():6-14. PubMed ID: 34563447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of liver disease state progression in patients with eradication of versus persistent infection with hepatitis C virus: Markov chain analysis.
    Tada T; Toyoda H; Kumada T; Kurisu A; Sugiyama A; Akita T; Ohisa M; Aikata H; Miki D; Chayama K; Tanaka J
    J Viral Hepat; 2021 Mar; 28(3):538-547. PubMed ID: 33215790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncologic Implications of Chronic Hepatitis C Virus Infection.
    Hwang JP; LoConte NK; Rice JP; Foxhall LE; Sturgis EM; Merrill JK; Torres HA; Bailey HH
    J Oncol Pract; 2019 Dec; 15(12):629-637. PubMed ID: 31825756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular Carcinoma Risk Declines but Remains High Enough for Screening in the First 7 Years After Hepatitis C Virus Cure With Direct-Acting Antivirals in Patients With Cirrhosis or High Fibrosis-4 Score.
    Kim NJ; Vutien P; Berry K; Ioannou GN
    Gastroenterology; 2022 Oct; 163(4):1104-1106.e3. PubMed ID: 35777481
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of dialysis patients with hepatitis C virus in the era of direct-acting antiviral therapy.
    Toyoda H; Kikuchi K
    Ther Apher Dial; 2023 Oct; 27(5):831-838. PubMed ID: 37217295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The curing regimens of HCV: A SWOT analysis.
    Cornberg M; Manns MP
    Antivir Ther; 2022; 27(1-2):13596535211072672. PubMed ID: 35491553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatitis C].
    Moradpour D; Blum HE
    Ther Umsch; 2004 Aug; 61(8):493-8. PubMed ID: 15457965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
    Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
    J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C: Standard of Treatment and What to Do for Global Elimination.
    Di Marco L; La Mantia C; Di Marco V
    Viruses; 2022 Feb; 14(3):. PubMed ID: 35336911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus cure before hepatocellular carcinoma diagnosis is associated with improved survival.
    Lockart I; Hajarizadeh B; Alavi M; Davison S; Prakoso E; Levy MT; George J; Dore GJ; Danta M
    J Viral Hepat; 2021 May; 28(5):710-718. PubMed ID: 33481322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: Effective Direct-Acting Antiviral Treatments Support Global and National Programs to Eliminate Hepatitis C.
    Parums DV
    Med Sci Monit; 2023 Apr; 29():e940519. PubMed ID: 37002682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of hepatocellular carcinoma after hepatitis C virus cure.
    Luna-Cuadros MA; Chen HW; Hanif H; Ali MJ; Khan MM; Lau DT
    World J Gastroenterol; 2022 Jan; 28(1):96-107. PubMed ID: 35125821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.